Skip to main content
. 2023 Apr 5;52(4):1231–1242. doi: 10.1093/ije/dyad040

Figure 1.

Figure 1

Flow chart illustrating participants included in each analysis. AD, atopic dermatitis; AR, allergic rhinoconjunctivitis